Close Menu

NEW YORK — German molecular diagnostics firm Curetis said today that it has hired US investment bank H.C. Wainwright to help it review strategic options for securing the money it needs to continue operations for at least the next 12 months.

Options under consideration include equity funding, an acquisition, merger, or business combination, Curetis said, adding that it does not intend to provide updates on the strategic assessment until a course of action is selected.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.